DEC TIMOTHY C (CIK 1194020) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Buy SUPN (1,250 shares), Sell SUPN (604 shares), Buy SUPN (3,000 shares), Sell SUPN (1,433 shares), Buy SUPN (3,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Senior Vice-President & CFO | Buy | 1,250 | $0 |
| 2026-08-14 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Senior Vice-President & CFO | Sell | 604 | $28,128 |
| 2026-03-10 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Senior Vice-President & CFO | Buy | 3,000 | $0 |
| 2026-03-10 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Senior Vice-President & CFO | Sell | 1,433 | $78,428 |
| 2026-03-10 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Senior Vice-President & CFO | Buy | 3,000 | $0 |
| 2026-03-10 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Senior Vice-President & CFO | Sell | 1,450 | $79,358 |
| 2026-02-26 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Senior Vice-President & CFO | Buy | 2,500 | $0 |
| 2026-02-26 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Senior Vice-President & CFO | Sell | 1,279 | $64,833 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Senior Vice-President & CFO | Buy | 1,125 | $0 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Senior Vice-President & CFO | Sell | 603 | $30,964 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Senior Vice-President & CFO | Buy | 500 | $0 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Senior Vice-President & CFO | Sell | 242 | $12,308 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Senior Vice-President & CFO | Buy | 3,000 | $0 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Senior Vice-President & CFO | Sell | 1,524 | $77,511 |
| 2025-08-26 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Senior Vice-President & CFO | Sell | 11,780 | $524,092 |
来源：SEC Form 4 申报文件 · 截至 2026-08-14